NDC 73687-062

UPNEEQ

Oxymetazoline Hydrochloride Ophthalmic

UPNEEQ is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Rvl Pharmaceuticals, Inc.. The primary component is Oxymetazoline Hydrochloride.

Product ID73687-062_22725084-2f0d-491f-b474-2e9ebb7a470a
NDC73687-062
Product TypeHuman Prescription Drug
Proprietary NameUPNEEQ
Generic NameOxymetazoline Hydrochloride Ophthalmic
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2020-08-21
Marketing CategoryNDA / NDA
Application NumberNDA212520
Labeler NameRVL Pharmaceuticals, Inc.
Substance NameOXYMETAZOLINE HYDROCHLORIDE
Active Ingredient Strength1 mg/mL
Pharm ClassesVasoconstrictor [EPC],Vasoconstriction [PE],Increased Sympathetic Activity [PE],Imidazolines [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 73687-062-25

15 AMPULE in 1 CARTON (73687-062-25) > .3 mL in 1 AMPULE (73687-062-80)
Marketing Start Date2020-08-21
NDC Exclude FlagN
Sample Package?Y

Drug Details


Trademark Results [UPNEEQ]

Mark Image

Registration | Serial
Company
Trademark
Application Date
UPNEEQ
UPNEEQ
90281158 not registered Live/Pending
RVL Pharmaceuticals, Inc.
2020-10-27
UPNEEQ
UPNEEQ
90244070 not registered Live/Pending
RVL Pharmaceuticals, Inc.
2020-10-09
UPNEEQ
UPNEEQ
90045944 not registered Live/Pending
RVL Pharmaceuticals, Inc.
2020-07-10
UPNEEQ
UPNEEQ
88791296 not registered Live/Pending
Vertical Pharmaceuticals, LLC
2020-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.